Future Therapies for AML including Mitostory, CPX-351, IDH-1, & IDH-2

Future Therapies for AML including Mitostory, CPX-351, IDH-1, & IDH-2

User Photo
ASHReport

4 years
1,058 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Sudipto Mukherjee, MD, MPH of Cleveland Clinic discusses several and recent developments in AML treatment at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>